{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:40:39Z","timestamp":1775634039725,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>A 56-year-old woman underwent surgery for clear cell renal cell carcinoma (ccRCC) 8 years ago. The patient incidentally discovered 2 foci in the body and tail of the pancreas by abdominal ultrasound during follow-up. MRI disclosed lesions with central inhomogeneous enhancement and restricted diffusion. The 2 lesions showed no <jats:sup>18<\/jats:sup>F-FDG uptake but had mild to moderate <jats:sup>68<\/jats:sup>Ga-FAPI accumulation in the PET\/CT images. Postoperative pathology and immunohistochemical analysis confirmed metastatic ccRCC to the pancreas. <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT might be a useful tool in the diagnosis and staging of ccRCC.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005730","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:01:32Z","timestamp":1740704492000},"page":"e608-e610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Rare Metastatic Clear Cell Renal Cell Carcinoma to Pancreas Revealed by 68Ga-FAPI PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"given":"Yunuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Fourth Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenglian","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-2643","authenticated-orcid":false,"given":"Xinming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University"},{"name":"Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University"},{"name":"Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"R1-20250903","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat Rev Urol"},{"key":"R2-20250903","doi-asserted-by":"crossref","first-page":"16292","DOI":"10.3390\/ijms242216292","article-title":"Genetic and epigenetic characteristics in isolated pancreatic metastases of clear-cell renal cell carcinoma","volume":"24","author":"Sellner","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R3-20250903","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00259-022-06101-3","article-title":"Head-to-head comparison of [(68)Ga]Ga-P16-093 and 2-[(18)F]FDG PET\/CT in patients with clear cell renal cell carcinoma: a pilot study","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20250903","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fonc.2016.00201","article-title":"The place of FDG PET\/CT in renal cell carcinoma: value and limitations","volume":"6","author":"Liu","year":"2016","journal-title":"Front Oncol"},{"key":"R5-20250903","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J Nucl Med"},{"key":"R6-20250903","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s00259-022-05706-y","article-title":"Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond","volume":"49","author":"Li","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20250903","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s12149-021-01673-w","article-title":"Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET\/CT","volume":"35","author":"Zheng","year":"2021","journal-title":"Ann Nucl Med"},{"key":"R8-20250903","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"R9-20250903","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/RLU.0000000000004607","article-title":"(68)Ga-FAPI-04 PET\/CT in a small sarcomatoid renal cell carcinoma with widespread metastases","volume":"48","author":"Dong","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R10-20250903","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/RLU.0000000000003454","article-title":"(68)Ga-fibroblast activation protein inhibitor, a promising radiopharmaceutical in PET\/CT to detect the primary and metastatic lesions of chromophobe renal cell carcinoma","volume":"46","author":"Pang","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R11-20250903","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1097\/RLU.0000000000004374","article-title":"Superiority of (68)Ga-FAPI-04 in delineation of soft tissue and liver metastases in chromophobe renal cell carcinoma for restaging","volume":"47","author":"Xie","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R12-20250903","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/RLU.0000000000004297","article-title":"Lipid-poor renal angiomyolipoma mimicking renal cell carcinoma on (68)Ga-FAPI-04 PET\/CT","volume":"47","author":"Dong","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R13-20250903","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/RLU.0000000000004207","article-title":"(68)Ga-FAPI-04 PET\/CT in solitary choroid plexus metastasis from renal cell carcinoma","volume":"47","author":"Yang","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:00:42Z","timestamp":1756933242000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005730","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"2024-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}